NQDI-1

1 1

Selleck Chemicals

S8289-10MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

NQDI-1 is an inhibitor linked to Apoptosis and related pathway-oriented research. In practice, this places the compound in experiments that measure caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and oxidative stress models.

The pathway annotation connects NQDI-1 to Apoptosis, supporting experiments that monitor caspase-associated cell-death signaling and survival decisions across biochemical, cellular, or phenotypic assay formats. This context is compatible with apoptosis, viability, and caspase-readout assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, cancer, and oxidative stress models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to Apoptosis
  • Concentration-response inhibition and target-dependence studies
  • Phenotypic profiling in apoptosis, cancer, and oxidative stress models
  • Combination studies with orthogonal perturbagens

Overall, NQDI-1 is well suited to pathway-oriented studies that need a defined compound input for Apoptosis readouts in apoptosis, cancer, and oxidative stress models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
Apoptosis
Research Area:
Apoptosis • Cancer • Oxidative Stress
CAS No.:
175026-96-7
Molecular Weight:
319.31
Formula:
C₁₉H₁₃NO₄
SMILES:
CCOC(=O)C1=C2C3=CC=CC=C3C(=O)C4=C2C(=CC=C4)NC1=O
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.